Itch draws our attention to allow imposing action against bodily harm (e.g., remove insects). At the same time, itch is found to interfere with ongoing tasks and daily life goals. Despite the key role of attention in itch processing, interventions that train individuals to automatically disengage attention from itch cues are lacking. The present proof-of-principle attention bias modification (ABM) training study was aimed at investigating whether attention to itch as well as sensitivity to mild itch can be changed. Healthy volunteers were randomized over three ABM-training conditions. Training was done via a modified pictorial dot-probe task. In particular, participants were trained to look away from itch stimuli ( = 38), toward itch stimuli ( = 40) or not trained toward or away from itch at all (sham training, = 38). The effects of the ABM-training were tested primarily on attention to itch pictures. Secondarily, it was investigated whether training effects generalized to alterations in attention to itch words and mechanical itch sensitivity. The ABM-training did not alter attention toward the itch pictures, and there was no moderation by baseline levels of attention bias for itch. Also, attention bias to the itch words and itch sensitivity were not affected by the ABM-training. This study was a first step toward trainings to change attention toward itch. Further research is warranted to optimize ABM-training methodology, for example increasing motivation of participants. Eventually, an optimized training could be used in patient populations who suffer most from distraction by their symptoms of itch. Identifier: NL6134 (NTR6273). The website URL is: https://www.trialregister.nl/.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278002PMC
http://dx.doi.org/10.3389/fmed.2021.627593DOI Listing

Publication Analysis

Top Keywords

attention itch
28
itch
19
attention bias
12
attention
11
bias modification
8
trained itch
8
itch stimuli
8
training effects
8
itch pictures
8
itch sensitivity
8

Similar Publications

IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid.

Front Immunol

December 2024

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Introduction: Bullous pemphigoid (BP) and prurigo nodularis (PN) are chronic pruritic skin diseases that severely impact patients' quality of life. Despite the widespread attention these two diseases have garnered within the dermatological field, the specific pathogenesis, particularly the molecular mechanisms underlying the pruritus, remains largely unclear. Limited clinical sequencing studies focusing on BP and PN have hindered the identification of pathological mechanisms and the exploration of effective treatment strategies.

View Article and Find Full Text PDF

Background: Risk factors and the temporal relationship between atopic dermatitis (AD) and atopic march remain understudied.

Objective: Determine risk factors for atopic march in early-onset AD patients and the temporality between AD and atopic march.

Methods: We used the MarketScan Research Database for our retrospective cohort analysis from 2010 to 2018, comparing infants diagnosed with AD before age 1 with controls without early-onset AD.

View Article and Find Full Text PDF

Usability evaluation and reporting for mobile health apps targeting patients with skin diseases: a systematic review.

Clin Exp Dermatol

October 2024

Oxford University Hospitals NHS Foundation Hospitals, Dermatology Department, Churchill Hospital, Headington, Oxford, UK.

Article Synopsis
  • Usability is crucial for mobile health apps, especially for skin disease patients, yet many apps lack proper design and evaluation.
  • The study analyzed the usability of 9 mobile health apps, finding that most were easy to use and effective, with major concerns around navigation, security, and customizability.
  • Acknowledging the gap between rapid app development and limited usability research, the study calls for improved user-centered design and thorough evaluation to enhance the adoption of these health apps.
View Article and Find Full Text PDF

Itch is a prominent symptom of atopic dermatitis (AD). However, the underlying mechanism remains complex and has not yet been fully elucidated. Mas-related G protein-coupled receptor A3 (MrgprA3) has emerged attention as a marker of primary sensory neurons that specifically transmit itch signals; however, its involvement in AD-related itch has not been extensively explored.

View Article and Find Full Text PDF
Article Synopsis
  • * A study of 100 Danish pharmacies revealed that 99% recommended terbinafine as the first-line treatment, but 88% of employees were unaware of antifungal resistance issues.
  • * The findings highlight a need for better awareness among pharmacy staff regarding antifungal resistance to ensure effective treatment and prevent its spread.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!